Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

Condition:   Atrial Fibrillation Interventions:   Drug: Apixaban monotherapy;   Drug: Dual therapy with apixaban and clopidogrel Sponsor:   Yonsei University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials